Regorafenib

Grey

Brand Name(s):Stivarga

Indication:Cancer – Colorectal (metastatic) in adults who have been previously treated with, or are not considered candidates for, available therapies.

Rationale:1

Considered:Jul-13

Review Date:Mar-20

Comments:
NICE TA 334
Terminated appraisal, full information at:https://www.nice.org.uk/guidance/ta334/resources/guidance-regorafenib-for-metastatic-colorectal-cancer-after-treatment-for-metastatic-disease-terminated-appraisal-pdf

February 2015